Atlas Trials

The Relative Bioavailability of INS068 Injection With Two Different Formulations in Healthy Subjects

Clinical trial NCT05336071 · COMPLETED

Trial details

NCT number
NCT05336071
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2022-05-12
Primary completion
2022-05-26
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.